Blog Collection

Blog Hero Image

THE FDA HEARD US LOUD AND CLEAR!

On September 11, the FDA held a half-day patient-focused drug development (PFDD) meeting focused exclusively on alopecia areata. The goal was to collect patient perspectives on current and potential treatment options and learn about the ways alopecia areata impacts our everyday lives. The FDA didn’t just listen to what we had to say, we piqued its curiosity. The agency is still asking for your comments through the “public docket” open until November 13, 2017. Learn More